Nicholas R. Bonenfant
University of Vermont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicholas R. Bonenfant.
Biomaterials | 2014
Darcy E. Wagner; Nicholas R. Bonenfant; Charles Parsons; Dino Sokocevic; Elice M. Brooks; Zachary D. Borg; Melissa J. Lathrop; John D. Wallis; Amanda B. Daly; Ying Wai Lam; Bin Deng; Michael J. DeSarno; Takamaru Ashikaga; Roberto Loi; Daniel J. Weiss
Acellular whole human lung scaffolds represent a unique opportunity for ex vivo tissue engineering. However, it remains unclear whether lungs from individuals with chronic lung diseases such as chronic obstructive pulmonary disease (COPD) can be appropriately decellularized and recellularized. To assess this, cadaveric human lungs from normal (non-smoking) patients and from patients with COPD (smoking history) were decellularized and found by histochemical and immunohistochemical staining, electron microscopy, and mass spectrometry to retain characteristic histological architecture and extracellular matrix components (ECM) reflecting either normal or COPD, particularly emphysematous, origin. Inoculation of human bronchial epithelial cells, endothelial progenitor cells, bone marrow-derived mesenchymal stem cells, and lung fibroblasts via airway or vascular routes into small, excised segments of the decellularized lungs demonstrated that normal lung scaffolds robustly supported initial engraftment and growth of each cell type for up to one month. In contrast, despite initial binding, all cell types inoculated into decellularized emphysematous lungs did not survive beyond one week. However, cell attachment and proliferation on solubilized ECM homogenates of decellularized normal and emphysematous lungs coated onto tissue culture plates was comparable and not impaired, suggesting that the 3-dimensional decellularized emphysematous scaffolds may lack the necessary ECM architecture to support sustained cell growth.
Biomaterials | 2014
Darcy E. Wagner; Nicholas R. Bonenfant; Dino Sokocevic; Michael J. DeSarno; Zachary D. Borg; Charles Parsons; Elice M. Brooks; Joseph Platz; Zain Khalpey; David M. Hoganson; Bin Deng; Ying W. Lam; Rachael A. Oldinski; Takamaru Ashikaga; Daniel J. Weiss
Acellular scaffolds from complex whole organs such as lung are being increasingly studied for ex vivo organ generation and for in vitro studies of cell-extracellular matrix interactions. We have established effective methods for efficient de and recellularization of large animal and human lungs including techniques which allow multiple small segments (∼ 1-3 cm(3)) to be excised that retain 3-dimensional lung structure. Coupled with the use of a synthetic pleural coating, cells can be selectively physiologically inoculated via preserved vascular and airway conduits. Inoculated segments can be further sliced for high throughput studies. Further, we demonstrate thermography as a powerful noninvasive technique for monitoring perfusion decellularization and for evaluating preservation of vascular and airway networks following human and porcine lung decellularization. Collectively, these techniques are a significant step forward as they allow high throughput in vitro studies from a single lung or lobe in a more biologically relevant, three-dimensional acellular scaffold.
Biomaterials | 2013
Dino Sokocevic; Nicholas R. Bonenfant; Darcy E. Wagner; Zachary D. Borg; Melissa J. Lathrop; Ying Wai Lam; Bin Deng; Michael J. DeSarno; Taka Ashikaga; Roberto Loi; A. M. Hoffman; Daniel J. Weiss
Use of de-cellularized cadaveric lungs as 3-dimensional scaffolds for ex vivo lung tissue generation offers a new potential therapeutic approach for clinical lung transplantation. However, it is likely that some of the available cadaveric human lungs may be from older donors or from donors with previously existing structural lung diseases such as emphysema or pulmonary fibrosis. It is not known whether these lungs will be suitable for either de-cellularization or re-cellularization. To investigate this, we assessed the effects of advanced age, representative emphysematous and fibrotic injuries, and the combination of advanced age and emphysematous injury and found significant differences both in histologic appearance and in the retention of extracellular matrix (ECM) and other proteins, as assessed by immunohistochemistry and mass spectrometry, between the different conditions. However, despite these differences, binding, retention and growth of bone marrow-derived mesenchymal stromal cells (MSCs) over a 1-month period following intratracheal inoculation were similar between the different experimental conditions. In contrast, significant differences occurred in the growth of C10 mouse lung epithelial cells between the different conditions. Therefore, age, lung injury, and the cell type used for re-cellularization may significantly impact the usefulness of de-cellularized whole lungs for ex vivo lung tissue regeneration.
Biomaterials | 2013
Nicholas R. Bonenfant; Dino Sokocevic; Darcy E. Wagner; Zachary D. Borg; Melissa J. Lathrop; Ying Wai Lam; Bin Deng; Michael J. DeSarno; Taka Ashikaga; Roberto Loi; Daniel J. Weiss
Despite growing interest on the potential use of de-cellularized whole lungs as 3-dimensional scaffolds for ex vivo lung tissue generation, optimal processing including sterilization and storage conditions, are not well defined. Further, it is unclear whether lungs need to be obtained immediately or may be usable even if harvested several days post-mortem, a situation mimicking potential procurement of human lungs from autopsy. We therefore assessed effects of delayed necropsy, prolonged storage (3 and 6 months), and of two commonly utilized sterilization approaches: irradiation or final rinse with peracetic acid, on architecture and extracellular matrix (ECM) protein characteristics of de-cellularized mouse lungs. These different approaches resulted in significant differences in both histologic appearance and in retention of ECM and intracellular proteins as assessed by immunohistochemistry and mass spectrometry. Despite these differences, binding and proliferation of bone marrow-derived mesenchymal stromal cells (MSCs) over a one month period following intratracheal inoculation was similar between experimental conditions. In contrast, significant differences occurred with C10 mouse lung epithelial cells between the different conditions. Therefore, delayed necropsy, duration of scaffold storage, sterilization approach, and cell type used for re-cellularization may significantly impact the usefulness of this biological scaffold-based model of ex vivo lung tissue regeneration.
PLOS ONE | 2015
Aurélie Crabbé; Yulong Liu; Shameema Sarker; Nicholas R. Bonenfant; Jennifer Barrila; Zachary D. Borg; James J. Lee; Daniel J. Weiss; Cheryl A. Nickerson
Strategies are needed to improve repopulation of decellularized lung scaffolds with stromal and functional epithelial cells. We demonstrate that decellularized mouse lungs recellularized in a dynamic low fluid shear suspension bioreactor, termed the rotating wall vessel (RWV), contained more cells with decreased apoptosis, increased proliferation and enhanced levels of total RNA compared to static recellularization conditions. These results were observed with two relevant mouse cell types: bone marrow-derived mesenchymal stromal (stem) cells (MSCs) and alveolar type II cells (C10). In addition, MSCs cultured in decellularized lungs under static but not bioreactor conditions formed multilayered aggregates. Gene expression and immunohistochemical analyses suggested differentiation of MSCs into collagen I-producing fibroblast-like cells in the bioreactor, indicating enhanced potential for remodeling of the decellularized scaffold matrix. In conclusion, dynamic suspension culture is promising for enhancing repopulation of decellularized lungs, and could contribute to remodeling the extracellular matrix of the scaffolds with subsequent effects on differentiation and functionality of inoculated cells.
Tissue Engineering Part C-methods | 2016
Joseph Platz; Nicholas R. Bonenfant; Franziska E. Uhl; Amy L. Coffey; Tristan McKnight; Charles Parsons; Dino Sokocevic; Zachary D. Borg; Ying Wai Lam; Bin Deng; Julia G. Fields; Michael J. DeSarno; Roberto Loi; A. M. Hoffman; John Bianchi; Brian Dacken; Thomas Petersen; Darcy E. Wagner; Daniel J. Weiss
BACKGROUND A novel potential approach for lung transplantation could be to utilize xenogeneic decellularized pig lung scaffolds that are recellularized with human lung cells. However, pig tissues express several immunogenic proteins, notably galactosylated cell surface glycoproteins resulting from alpha 1,3 galactosyltransferase (α-gal) activity, that could conceivably prevent effective use. Use of lungs from α-gal knock out (α-gal KO) pigs presents a potential alternative and thus comparative de- and recellularization of wild-type and α-gal KO pig lungs was assessed. METHODS Decellularized lungs were compared by histologic, immunohistochemical, and mass spectrometric techniques. Recellularization was assessed following compartmental inoculation of human lung bronchial epithelial cells, human lung fibroblasts, human bone marrow-derived mesenchymal stromal cells (all via airway inoculation), and human pulmonary vascular endothelial cells (CBF) (vascular inoculation). RESULTS No obvious differences in histologic structure was observed but an approximate 25% difference in retention of residual proteins was determined between decellularized wild-type and α-gal KO pig lungs, including retention of α-galactosylated epitopes in acellular wild-type pig lungs. However, robust initial recellularization and subsequent growth and proliferation was observed for all cell types with no obvious differences between cells seeded into wild-type versus α-gal KO lungs. CONCLUSION These proof of concept studies demonstrate that decellularized wild-type and α-gal KO pig lungs can be comparably decellularized and comparably support initial growth of human lung cells, despite some differences in retained proteins. α-Gal KO pig lungs are a suitable platform for further studies of xenogeneic lung regeneration.
Tissue Engineering Part C-methods | 2016
Barbora Zvarova; Franziska E. Uhl; Juan J. Uriarte; Zachary D. Borg; Amy L. Coffey; Nicholas R. Bonenfant; Daniel J. Weiss; Darcy E. Wagner
Cellular and Molecular Bioengineering | 2014
Darcy E. Wagner; Spencer L. Fenn; Nicholas R. Bonenfant; Elliot R. Marks; Zachary D. Borg; Patrick Saunders; Rachael A. Oldinski; Daniel J. Weiss
Transplantation Research | 2014
Saverio La Francesca; Anthony E. Ting; Jason Sakamoto; Jessica Rhudy; Nicholas R. Bonenfant; Zachary D. Borg; Fernanda F. Cruz; Meagan Goodwin; Nicholas Lehman; Jennifer M Taggart; Robert Deans; Daniel J. Weiss
Tissue Engineering Part C-methods | 2016
Joseph Platz; Nicholas R. Bonenfant; Franziska E. Uhl; Amy L. Coffey; Tristan McKnight; Charles Parsons; Dino Sokocevic; Zachary D. Borg; Ying Wai Lam; Bin Deng; Julia G. Fields; Michael J. DeSarno; Roberto Loi; A. M. Hoffman; John Bianchi; Brian Dacken; Thomas N Petersen; Darcy E. Wagner; Daniel J. Weiss